Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1961 2
1963 1
1964 5
1966 3
1967 3
1968 2
1969 4
1970 1
1973 1
1974 3
1975 1
1976 3
1977 2
1978 1
1979 1
1980 3
1981 1
1982 4
1983 5
1984 3
1985 2
1986 8
1987 8
1988 7
1989 6
1990 3
1991 10
1992 4
1993 16
1994 20
1995 11
1996 22
1997 18
1998 28
1999 20
2000 48
2001 48
2002 44
2003 64
2004 53
2005 66
2006 87
2007 104
2008 107
2009 104
2010 137
2011 155
2012 132
2013 151
2014 142
2015 160
2016 175
2017 189
2018 152
2019 171
2020 198
2021 216
2022 195
2023 177
2024 79

Text availability

Article attribute

Article type

Publication date

Search Results

3,023 results

Results by year

Filters applied: . Clear all
Page 1
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Motzer RJ, McDermott DF, Escudier B, Burotto M, Choueiri TK, Hammers HJ, Barthélémy P, Plimack ER, Porta C, George S, Powles T, Donskov F, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Tomita Y, Castellano D, Grünwald V, Rini BI, McHenry MB, Lee CW, McCarthy J, Ejzykowicz F, Tannir NM. Motzer RJ, et al. Among authors: lee cw. Cancer. 2022 Jun 1;128(11):2085-2097. doi: 10.1002/cncr.34180. Epub 2022 Apr 5. Cancer. 2022. PMID: 35383908 Free PMC article. Clinical Trial.
Oral Contraceptive Use Impairs Muscle Gains in Young Women.
Riechman SE, Lee CW. Riechman SE, et al. Among authors: lee cw. J Strength Cond Res. 2022 Nov 1;36(11):3074-3080. doi: 10.1519/JSC.0000000000004059. Epub 2021 May 14. J Strength Cond Res. 2022. PMID: 33993156
Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice.
Ahuja P, Ng CF, Pang BPS, Chan WS, Tse MCL, Bi X, Kwan HR, Brobst D, Herlea-Pana O, Yang X, Du G, Saengnipanthkul S, Noh HL, Jiao B, Kim JK, Lee CW, Ye K, Chan CB. Ahuja P, et al. Among authors: lee cw. Autophagy. 2022 Jun;18(6):1367-1384. doi: 10.1080/15548627.2021.1985257. Epub 2021 Oct 25. Autophagy. 2022. PMID: 34689722 Free PMC article.
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.
Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, Yong JN, Xiao J, Lee CW, Chan M, Chew NW, Xuan Tan EX, Siddiqui MS, Huang D, Noureddin M, Sanyal AJ, Muthiah MD. Lim GEH, et al. Among authors: lee cw. Clin Gastroenterol Hepatol. 2023 Mar;21(3):619-629.e7. doi: 10.1016/j.cgh.2021.11.038. Epub 2021 Dec 4. Clin Gastroenterol Hepatol. 2023. PMID: 34871813 Review.
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.
Albiges L, Tannir NM, Burotto M, McDermott D, Plimack ER, Barthélémy P, Porta C, Powles T, Donskov F, George S, Kollmannsberger CK, Gurney H, Grimm MO, Tomita Y, Castellano D, Rini BI, Choueiri TK, Leung D, Saggi SS, Lee CW, McHenry MB, Motzer RJ. Albiges L, et al. Among authors: lee cw. Eur Urol. 2022 Mar;81(3):266-271. doi: 10.1016/j.eururo.2021.10.001. Epub 2021 Nov 5. Eur Urol. 2022. PMID: 34750035 Free PMC article. Clinical Trial.
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma.
Rini BI, Signoretti S, Choueiri TK, McDermott DF, Motzer RJ, George S, Powles T, Donskov F, Tykodi SS, Pal SK, Gupta S, Lee CW, Jiang R, Tannir NM. Rini BI, et al. Among authors: lee cw. J Immunother Cancer. 2022 Dec;10(12):e005445. doi: 10.1136/jitc-2022-005445. J Immunother Cancer. 2022. PMID: 36549781 Free PMC article. Clinical Trial.
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial.
Arntz A, Jacob GA, Lee CW, Brand-de Wilde OM, Fassbinder E, Harper RP, Lavender A, Lockwood G, Malogiannis IA, Ruths FA, Schweiger U, Shaw IA, Zarbock G, Farrell JM. Arntz A, et al. Among authors: lee cw. JAMA Psychiatry. 2022 Apr 1;79(4):287-299. doi: 10.1001/jamapsychiatry.2022.0010. JAMA Psychiatry. 2022. PMID: 35234828 Free PMC article. Clinical Trial.
3,023 results